3.88
price down icon6.05%   -0.25
after-market アフターアワーズ: 3.88
loading
前日終値:
$4.13
開ける:
$4.15
24時間の取引高:
548.33K
Relative Volume:
0.56
時価総額:
$246.62M
収益:
$157.08M
当期純損益:
$-70.36M
株価収益率:
-3.4905
EPS:
-1.1116
ネットキャッシュフロー:
$-71.69M
1週間 パフォーマンス:
-0.77%
1か月 パフォーマンス:
-8.71%
6か月 パフォーマンス:
+187.41%
1年 パフォーマンス:
+158.67%
1日の値動き範囲:
Value
$3.845
$4.15
1週間の範囲:
Value
$3.81
$4.245
52週間の値動き範囲:
Value
$1.185
$4.6401

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1107)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
293
Name
Twitter
@macrogenics
Name
次回の収益日
2026-05-12
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MGNX icon
MGNX
Macrogenics Inc
3.88 262.52M 157.08M -70.36M -71.69M -1.1116
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
453.17 114.33B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
614.73 64.47B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
878.49 54.99B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
281.90 38.42B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
156.58 34.03B 742.00K -1.37B -1.07B -7.0731

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 アップグレード B. Riley Securities Neutral → Buy
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
Jun 12, 2026

MacroGenics Inc Stock (US5562221046): Valuation metrics in focus after recent biotech swing - AD HOC NEWS

Jun 12, 2026
pulisher
Jun 06, 2026

How The MacroGenics (MGNX) Story Is Shifting With ADC Pipeline Bets And 2026 Data Risks - Yahoo Finance

Jun 06, 2026
pulisher
Jun 05, 2026

Millennium Group and Israel Englander report 3.44M MGNX shares (5.4%) - Stock Titan

Jun 05, 2026
pulisher
May 31, 2026

MacroGenics eyes $200M cash boost, 2028 runway ahead of cancer pipeline updates - MSN

May 31, 2026
pulisher
May 29, 2026

MacroGenics expands ZYNYZ royalty deal with Sagard, secures $60M upfront - MSN

May 29, 2026
pulisher
May 29, 2026

MacroGenics Inc stock (US5562221046): shares ease after strong year-to-date run amid biotech volatil - AD HOC NEWS

May 29, 2026
pulisher
May 28, 2026

Will MacroGenics (MGNX) report negative Q1 earnings? What you should know - MSN

May 28, 2026
pulisher
May 27, 2026

Macrogenics(MGNX) Stock Options Chain | Quotes & News - Moomoo

May 27, 2026
pulisher
May 27, 2026

MacroGenics, Inc. (MGNX) Latest Stock News & Headlines - Yahoo Finance

May 27, 2026
pulisher
May 27, 2026

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates - TradingView

May 27, 2026
pulisher
May 25, 2026

MacroGenics, Inc. Hits New 52-Week High of $4.64 - Markets Mojo

May 25, 2026
pulisher
May 24, 2026

MacroGenics to sell manufacturing operations to Bora for $122.5M - MSN

May 24, 2026
pulisher
May 22, 2026

MacroGenics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

May 22, 2026
pulisher
May 21, 2026

How The MacroGenics (MGNX) Story Is Shifting With ADC Hopes And Execution Risks - Yahoo Finance

May 21, 2026
pulisher
May 21, 2026

MacroGenics stock (US5562221046): insider equity grants follow 2026 shareholder meeting - AD HOC NEWS

May 21, 2026
pulisher
May 20, 2026

MacroGenics Shareholders Back Board, Auditors and Equity Plan - TipRanks

May 20, 2026
pulisher
May 20, 2026

MACROGENICS (MGNX) director O'Brien receives RSUs and 22,000-share option grant - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) director receives new options and RSU awards - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) director granted options, RSUs and stock - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) director converts 3,750 RSUs into common shares - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) director awarded options, RSUs and exercises prior grant - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MACROGENICS (MGNX) director Meenu Chhabra gets RSUs, options and RSU vesting - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MACROGENICS (MGNX) director granted options, RSUs and exercises awards - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MACROGENICS (MGNX) director David C. Stump gets new options and RSUs - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) director granted options and RSUs, RSUs vest into shares - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) awards stock options and RSUs to director Koenig - Stock Titan

May 20, 2026
pulisher
May 20, 2026

MacroGenics (MGNX) investors back board slate and expand 2023 equity plan - Stock Titan

May 20, 2026
pulisher
May 19, 2026

MacroGenics stock (US5562221046): biotech shares jump after Vyloy FDA approval and takeover deal - AD HOC NEWS

May 19, 2026
pulisher
May 18, 2026

MacroGenics appoints new CEO - MSN

May 18, 2026
pulisher
May 18, 2026

Macrogenics (MGNX) News Flow - Moomoo

May 18, 2026
pulisher
May 17, 2026

MacroGenics stock (US5562221046): FDA hold lifted and shares among May’s biotech gainers - AD HOC NEWS

May 17, 2026
pulisher
May 17, 2026

MacroGenics (MGNX) price target increased by 50.00% to 6.12 - MSN

May 17, 2026
pulisher
May 17, 2026

MacroGenics gains removal of FDA partial hold on lead program - MSN

May 17, 2026
pulisher
May 16, 2026

Bora Group to acquire MacroGenics manufacturing for 122.5 million - MSN

May 16, 2026
pulisher
May 16, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

May 16, 2026
pulisher
May 16, 2026

Bora to acquire MacroGenics‘ biologics manufacturing facility in Maryland - megaproject.com

May 16, 2026
pulisher
May 16, 2026

MacroGenics sells manufacturing arm to Bora in $123m deal - The Pharma Letter

May 16, 2026
pulisher
May 15, 2026

MacroGenics, Inc.Common Stock (NQ: MGNX - The Chronicle-Journal

May 15, 2026
pulisher
May 15, 2026

Armistice Capital (MGNX) reports 6.01M-share, 9.46% stake in Macrogenics - Stock Titan

May 15, 2026
pulisher
May 15, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

MacroGenics Reaches US$219m Market Cap Benefiting Insider Stock Buying - Moomoo

May 15, 2026
pulisher
May 14, 2026

Millennium Group reports 3.07M-share stake in MacroGenics (MGNX) - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Bank of America (NASDAQ: MGNX) reports 5.1% ownership in MacroGenics - Stock Titan

May 14, 2026
pulisher
May 14, 2026

MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum - The Manila Times

May 14, 2026
pulisher
May 14, 2026

Macrogenics Cash, Cash Equivalents and Marketable Securities Balance of $154.2 M as of March 31 >MGNX - Moomoo

May 14, 2026
pulisher
May 14, 2026

Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $4 - Moomoo

May 14, 2026
pulisher
May 14, 2026

Bora Pharmaceuticals to Acquire MacroGenics Manufacturing Facility in $122.5 Million Deal - biobuzz.io

May 14, 2026
pulisher
May 14, 2026

Barclays Maintains Macrogenics(MGNX.US) With Buy Rating, Maintains Target Price $6 - Moomoo

May 14, 2026
pulisher
May 14, 2026

Key facts: MacroGenics Q1 +58% revenue; $36.8M loss; LINNET 4 responses - TradingView

May 14, 2026
pulisher
May 14, 2026

Is MacroGenics (MGNX) 10.6% Undervalued After Q1 2026 Beat? EPS - GuruFocus

May 14, 2026
pulisher
May 14, 2026

MacroGenics (MGNX) reports Q1 loss, tops revenue estimates - MSN

May 14, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Macrogenics Inc (MGNX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
HEIDEN WILLIAM K
Director
Aug 19 '25
Buy
1.52
50,500
76,760
61,500
HEIDEN WILLIAM K
Director
Aug 20 '25
Buy
1.49
49,500
73,755
111,000
Koenig Scott
Director
Aug 13 '25
Option Exercise
0.00
52,829
0
830,244
$30.41
price up icon 1.27%
$55.40
price up icon 6.27%
$89.50
price down icon 1.43%
$54.21
price down icon 0.11%
ONC ONC
$263.92
price down icon 1.60%
$156.58
price down icon 2.17%
大文字化:     |  ボリューム (24 時間):